Interleukin-6 (IL-6) is a pro-inflammatory cytokine that sits upstream in the inflammatory cascade. When the immune system is activated by infection, tissue injury, or autoimmune processes, IL-6 is one of the signalling molecules that triggers the liver to produce C-reactive protein (CRP) and other acute phase reactants. Measuring IL-6 directly gives a more immediate view of inflammatory signalling than waiting for the downstream CRP response.
IL-6 has a short half-life in the blood, typically just a few hours. This means it responds rapidly to changes in inflammatory activity, rising and falling faster than CRP. A single elevated reading can reflect a very recent immune event, so timing and context matter when interpreting results. Persistently elevated IL-6 at lower thresholds is more informative for chronic low-grade inflammation than a single snapshot.
Clinically, IL-6 testing is used in the investigation of chronic inflammatory conditions, autoimmune diseases, and complex systemic illness where standard markers like CRP and ESR have not provided a clear picture. It became more widely recognised during the COVID-19 pandemic because cytokine storms involving massive IL-6 release were associated with severe disease outcomes.
This is a specialised test that requires careful sample handling in the laboratory. It is not part of standard inflammatory panels and is typically ordered by rheumatologists, immunologists, or practitioners with experience in inflammatory medicine. IL-6 is most valuable when interpreted alongside CRP, ESR, and the broader clinical picture rather than used as a standalone screening marker.
Factors that can temporarily elevate IL-6 include strenuous exercise, acute illness, poor sleep, obesity, and chronic psychological stress. For the most representative result, avoid vigorous physical activity in the days before testing and attend for collection when you are feeling relatively well, unless your practitioner has specifically asked you to test during a flare.
IL-6 testing is used when a more direct view of inflammatory signalling is needed. It's relevant in the investigation of chronic inflammatory conditions, autoimmune disease, and in tracking inflammatory activity that may not be fully captured by CRP or ESR alone. IL-6 has a shorter half-life than CRP, meaning it may reflect very recent immune activity more accurately.
